Geriatric Medicine, Edinburgh Delirium Research Group, Usher Institute, University of Edinburgh, Edinburgh, Scotland, UK.
School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK.
BMC Geriatr. 2021 Mar 5;21(1):162. doi: 10.1186/s12877-021-02095-z.
BACKGROUND: Delirium is a heterogeneous syndrome with inattention as the core feature. There is considerable variation in the presence and degree of other symptom domains such as altered arousal, psychotic features and global cognitive dysfunction. Delirium is independently associated with increased mortality, but it is unclear whether individual symptom domains of delirium have prognostic importance. We conducted a systematic review and meta-analysis of studies in hospitalised adults in general settings to identify the relationship between symptom domains of delirium and outcomes. (PROSPERO: CRD42018093935). METHODS: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, clinicaltrials.gov and the Cochrane Central Register of Controlled Trials from inception to November 2019. We included studies of hospitalised adults that reported associations between symptom domains of delirium and 30-day mortality (primary outcome), and other outcomes including mortality at other time points, length of stay, and dementia. Reviewer pairs independently screened articles, extracted data, and assessed risk of bias (Risk of Bias Assessment tool for Non-randomized Studies) and quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluation framework. We performed random-effects meta-analyses stratified by delirium domain where possible. RESULTS: From 7092 citations we included 6 studies (6002 patients, 1112 with delirium). Higher mortality (ranging from in-hospital to follow-up beyond 12 months) was associated with altered arousal (pooled Odds Ratio (OR) 2.80, 95% Confidence Interval (CI) 2.33-3.37; moderate-quality evidence), inattention (pooled OR 2.57, 95% CI 1.74-3.80; low-quality evidence), and in single studies with disorientation, memory deficits and disorganised thoughts. Risk of bias varied across studies but was moderate-to-high overall, mainly due to selection bias, lack of blinding of assessments and unclear risk of selective outcome reporting. We found no studies on the association between psychotic features, visuospatial deficits or affective disturbances in delirium and outcomes, or studies reporting non-mortality outcomes. CONCLUSIONS: Few studies have related symptom domains of delirium to outcomes, but the available evidence suggests that altered arousal and inattention in delirium are associated with higher mortality than normal arousal and attention in people with or without delirium. Measurable symptom domains of delirium may have value in predicting survival and stratifying patients for treatment. We recommend that future delirium studies report outcomes by symptom domain.
背景:谵妄是一种以注意力不集中为核心特征的异质综合征。其他症状域(如警觉度改变、精神病特征和全面认知功能障碍)的存在和严重程度存在相当大的差异。谵妄与死亡率增加独立相关,但尚不清楚谵妄的各个症状域是否具有预后意义。我们对一般环境下住院成人的研究进行了系统评价和荟萃分析,以确定谵妄症状域与结局之间的关系。(PROSPERO:CRD42018093935)。
方法:我们检索了 MEDLINE、EMBASE、PsycINFO、CINAHL、clinicaltrials.gov 和 Cochrane 对照试验中心注册库,从建库到 2019 年 11 月。我们纳入了报告谵妄症状域与 30 天死亡率(主要结局)以及其他结局(包括其他时间点的死亡率、住院时间和痴呆)之间关系的住院成人研究。审查员对文章进行了独立筛选、提取数据,并使用推荐评估、制定与评价分级框架(Grading of Recommendations,Assessment,Development and Evaluation framework)评估了偏倚风险(非随机研究的偏倚风险评估工具)和证据质量。在可能的情况下,我们对谵妄域进行了分层随机效应荟萃分析。
结果:从 7092 条引文中,我们纳入了 6 项研究(6002 名患者,1112 名患有谵妄)。较高的死亡率(范围从住院到 12 个月以上的随访)与警觉度改变(汇总优势比(OR)2.80,95%置信区间(CI)2.33-3.37;中等质量证据)、注意力不集中(汇总 OR 2.57,95% CI 1.74-3.80;低质量证据)有关,在个别研究中还与定向障碍、记忆缺陷和思维紊乱有关。研究间的偏倚风险不同,但总体上为中至高,主要是由于选择偏倚、评估缺乏盲法和选择性结局报告的风险不明确。我们没有发现关于谵妄中精神病特征、视觉空间缺陷或情感障碍与结局之间的关联的研究,也没有报告非死亡率结局的研究。
结论:很少有研究将谵妄的症状域与结局联系起来,但现有证据表明,与无谵妄或有谵妄的人相比,谵妄中的警觉度改变和注意力不集中与死亡率升高有关。可衡量的谵妄症状域可能在预测生存和分层治疗患者方面具有价值。我们建议未来的谵妄研究按症状域报告结局。
Cochrane Database Syst Rev. 2022-2-1
Cochrane Database Syst Rev. 2021-7-19
Cochrane Database Syst Rev. 2021-11-26
Cochrane Database Syst Rev. 2018-8-21
Cochrane Database Syst Rev. 2019-9-3
Cochrane Database Syst Rev. 2021-11-8
Cochrane Database Syst Rev. 2019-3-25
Cochrane Database Syst Rev. 2018-11-23
Cochrane Database Syst Rev. 2015-10-6
Worldviews Evid Based Nurs. 2025-6
Front Aging Neurosci. 2023-8-15
Alzheimers Dement. 2024-1
Nat Rev Dis Primers. 2020-11-12
J Am Med Dir Assoc. 2020-4
JAMA Intern Med. 2019-2-1
Int J Geriatr Psychiatry. 2018-5-31